H

Humasis Co Ltd
KOSDAQ:205470

Watchlist Manager
Humasis Co Ltd
KOSDAQ:205470
Watchlist
Price: 1 684 KRW 3.63% Market Closed
Market Cap: 217.9B KRW
Have any thoughts about
Humasis Co Ltd?
Write Note

Humasis Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Humasis Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
H
Humasis Co Ltd
KOSDAQ:205470
Income from Continuing Operations
-â‚©30.2B
CAGR 3-Years
N/A
CAGR 5-Years
-68%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Income from Continuing Operations
-â‚©467.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
BioPlus Co Ltd
KOSDAQ:099430
Income from Continuing Operations
â‚©27.4B
CAGR 3-Years
41%
CAGR 5-Years
64%
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Income from Continuing Operations
-â‚©201.5B
CAGR 3-Years
-48%
CAGR 5-Years
-26%
CAGR 10-Years
-40%
T
T&L Co Ltd
KOSDAQ:340570
Income from Continuing Operations
â‚©27.4B
CAGR 3-Years
40%
CAGR 5-Years
43%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Income from Continuing Operations
â‚©1.8B
CAGR 3-Years
-43%
CAGR 5-Years
-36%
CAGR 10-Years
-13%
No Stocks Found

Humasis Co Ltd
Glance View

Market Cap
217.9B KRW
Industry
Health Care

Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2014-12-01. The firm is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.

Intrinsic Value
1 657.93 KRW
Overvaluation 2%
Intrinsic Value
Price
H

See Also

What is Humasis Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-30.2B KRW

Based on the financial report for Sep 30, 2024, Humasis Co Ltd's Income from Continuing Operations amounts to -30.2B KRW.

What is Humasis Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-68%

Over the last year, the Income from Continuing Operations growth was 61%.

Back to Top